These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 23168752)

  • 1. Preventing unintended pregnancies by providing no-cost contraception.
    Peipert JF; Madden T; Allsworth JE; Secura GM
    Obstet Gynecol; 2012 Dec; 120(6):1291-7. PubMed ID: 23168752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing Unintended Pregnancy: The Contraceptive CHOICE Project in Review.
    Birgisson NE; Zhao Q; Secura GM; Madden T; Peipert JF
    J Womens Health (Larchmt); 2015 May; 24(5):349-53. PubMed ID: 25825986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Provision of no-cost, long-acting contraception and teenage pregnancy.
    Secura GM; Madden T; McNicholas C; Mullersman J; Buckel CM; Zhao Q; Peipert JF
    N Engl J Med; 2014 Oct; 371(14):1316-23. PubMed ID: 25271604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of unintended pregnancy at 12 months between two contraceptive care programs; a controlled time-trend design.
    Madden T; Paul R; Maddipati R; Buckel C; Goodman M; Peipert JF
    Contraception; 2019 Sep; 100(3):196-201. PubMed ID: 31132346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards regional equality in family planning: teenage pregnancies and abortions in Finland from 1976 to 1993.
    Kosunen EA; Rimpelä MK
    Acta Obstet Gynecol Scand; 1996 Jul; 75(6):540-7. PubMed ID: 8693930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contraception after Abortion and Risk of Repeated Unintended Pregnancy among Health Plan Members.
    Postlethwaite D; Lee J; Merchant M; Alabaster A; Raine-Bennett T
    Perm J; 2018; 22():18-058. PubMed ID: 30227910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-acting reversible contraception: a practical solution to reduce unintended pregnancy.
    Secura G
    Minerva Ginecol; 2013 Jun; 65(3):271-7. PubMed ID: 23689169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immediate postabortion initiation of levonorgestrel implants reduces the incidence of births and abortions at 2 years and beyond.
    Rose SB; Garrett SM; Stanley J
    Contraception; 2015 Jul; 92(1):17-25. PubMed ID: 25818594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors that influence the choice of long-acting reversible contraceptive use among adolescents post-abortion in Chongqing, China: a cross-sectional study.
    Jin F; Yang Y; Sun J; Li R; Yao F; Liu X
    J Obstet Gynaecol; 2024 Dec; 44(1):2316625. PubMed ID: 38353518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of long-acting reversible contraception.
    Winner B; Peipert JF; Zhao Q; Buckel C; Madden T; Allsworth JE; Secura GM
    N Engl J Med; 2012 May; 366(21):1998-2007. PubMed ID: 22621627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of publicly funded contraceptive services on unintended pregnancies and implications for Medicaid expenditures.
    Forrest JD; Samara R
    Fam Plann Perspect; 1996; 28(5):188-95. PubMed ID: 8886761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicaid savings from the Contraceptive CHOICE Project: a cost-savings analysis.
    Madden T; Barker AR; Huntzberry K; Secura GM; Peipert JF; McBride TD
    Am J Obstet Gynecol; 2018 Dec; 219(6):595.e1-595.e11. PubMed ID: 30194049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential impact of improvements in contraception on fertility and abortion in Western countries.
    Westoff CF; Hammerslough CR; Paul L
    Eur J Popul; 1987 Nov; 3(1):7-32. PubMed ID: 12280731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attitudes toward long-acting reversible contraception among young women seeking abortion.
    Rose SB; Cooper AJ; Baker NK; Lawton B
    J Womens Health (Larchmt); 2011 Nov; 20(11):1729-35. PubMed ID: 21923281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics and contraceptive practices among Chinese women seeking abortion: a multicentre, descriptive study from 2019 to 2021.
    Tu P; Hu D; Wu S; Li J; Jiang X; Pei K; Zhang WH
    BMJ Sex Reprod Health; 2024 Oct; 50(4):252-261. PubMed ID: 38702180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twenty-four-month continuation of reversible contraception.
    O'Neil-Callahan M; Peipert JF; Zhao Q; Madden T; Secura G
    Obstet Gynecol; 2013 Nov; 122(5):1083-1091. PubMed ID: 24104781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
    Hubacher D; Spector H; Monteith C; Chen PL; Hart C
    Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meeting the Contraceptive Needs of a Community: Increasing Access to Long-Acting Reversible Contraception.
    McNicholas C; Madden T
    Mo Med; 2017; 114(3):163-167. PubMed ID: 30228573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The complex relationship between contraception and abortion.
    Cleland J
    Best Pract Res Clin Obstet Gynaecol; 2020 Jan; 62():90-100. PubMed ID: 31196674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
    Steinauer JE; Upadhyay UD; Sokoloff A; Harper CC; Diedrich JT; Drey EA
    Contraception; 2015 Dec; 92(6):553-9. PubMed ID: 26093190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.